Background Brain-derived neurotrophic factor (BDNF) has been suggested to support dopaminergic neuron’s endurance and dopamine release. Its Val66Met polymorphism might modify Parkinson’s disease (PD) evolution, although evidence in Asian populations remains limited. This study aimed to explore how the BDNF rs6265 genotypes are associated with the clinical characteristics and longitudinal progression patterns of PD patients in a Korean population.
Methods A total of 247 patients were enrolled and followed for a mean duration of 50.9 ± 23.9 months. Baseline and/or periodic assessments captured motor severity, non-motor burden, cognition, orthostatic stress, cardiac denervation, and presynaptic dopamine transporter availability. The repeated measures were manipulated to infer any genotypic differences in the trajectories of each clinical domain.
Results Genotype frequencies were 31.2% (77/247) for Val/Val and 68.8% (170/247) for Met-allele carriers. Baseline clinical characteristics and presynaptic dopamine transporter availability were comparable between genotypes; however, Val homozygotes showed more preserved myocardial innervation and poorer non-frontal cognitive performance. Longitudinal analyses demonstrated genotype-specific increases in motor and cognitive severity. Compared to Met-allele carriers, the homozygous Val group exhibited accelerated motor progression and more rapid decline in frontal domain after three years of follow-up.
Conclusions The differences in myocardial denervation at diagnosis, cognitive profiles, and motor progression might suggest a potential modulatory role of BDNF polymorphism in PD progression in the Korean population.
Recent neuropathological and imaging studies support the concept of “brain-first vs. body-first” Parkinson’s disease (PD), which is based on the α-synuclein origin site and connectome model. The body-first phenotype is characterized by early involvement of the peripheral autonomic nervous system, particularly the cardiac sympathetic nerves and enteric nerves. 123I-meta-iodobenzylguanidine (123I-MIBG) myocardial scintigraphy is a well-established method for evaluating cardiac sympathetic innervation. This review explores the potential of 123I-MIBG scintigraphy as a biomarker to differentiate the body-first phenotype from the brain-first phenotype. Reduced 123I-MIBG uptake has been observed in idiopathic rapid eye movement (REM) sleep behavior disorder, pure autonomic failure, and incidental Lewy body disease—conditions strongly associated with prodromal or early-stage PD. Postmortem and biopsy evidence indicates α-synuclein accumulation in cardiac nerves and other peripheral sites, which is consistent with bottom-up progression. α-Synuclein seed amplification assays further corroborate the association between the peripheral α-synuclein burden and reduced 123I-MIBG uptake. While 123I-MIBG myocardial scintigraphy is a promising tool, its limitations include cost, limited availability, and potential confounding from underlying cardiac conditions. Nonetheless, early detection of cardiac sympathetic denervation via 123I-MIBG imaging may enhance diagnosis, support subtype classification, and improve the understanding of PD pathogenesis.
Citations
Citations to this article as recorded by
Letter to the editor: B-type natriuretic peptide in Parkinson's disease: a novel biomarker of dysautonomia Manxing Zhou, Tianmei Zhou Parkinsonism & Related Disorders.2026; 142: 108123. CrossRef
Primary Cueing Tremor: A Task-Specific Tremor of Billiard Players Thananan Thammongkolchai, Lee E. Neilson, Pichet Termsarasab Tremor and Other Hyperkinetic Movements.2025;[Epub] CrossRef
Analysis of arm, back and leg strength on the quality of power control in billiard sports Heryanto Nur Muhammad, Noortje Anita Kumaat, Nurkholis Nurkholis, Nur Ahmad Arief, Lutfhi Abdil Khuddus, Novadri Ayubi Health, sport, rehabilitation.2024; 10(1): 20. CrossRef
Positional head tremor in professional billiards player Mehri Salari, Ronak Rashedi, Nahid Beladi Moghadam, Masoud Etemadifar Acta Neurologica Belgica.2024; 124(6): 2079. CrossRef
Long-Term Muscular Atrophy and Weakness Following Cessation of Botulinum Toxin Type A Injections in the Flexor Digitorum Muscle of Musicians with Focal Hand Dystonia Christos I. Ioannou, Franziska L. Hodde-Chriske, Eckart Altenmüller Toxins.2023; 15(4): 296. CrossRef
Abnormal movements “Motare” in Kyudo have the characteristics of task—specific focal dystonia Taichi Ogiso, Yoya Ono, Saiki Suzuki, Takayoshi Shimohata Rinsho Shinkeigaku.2023; 63(8): 532. CrossRef
It's in the game: A review of neurological lesions associated with sports Mariana Pedrosa, Bárbara Martins, Rui Araújo Journal of the Neurological Sciences.2023; 455: 122803. CrossRef
Function and dysfunction of the dystonia network: an exploration of neural circuits that underlie the acquired and isolated dystonias Jason S. Gill, Megan X. Nguyen, Mariam Hull, Meike E. van der Heijden, Ken Nguyen, Sruthi P. Thomas, Roy V. Sillitoe Dystonia.2023;[Epub] CrossRef
Blacksmith’s Dystonia Is Another Task-Specific Dystonia: From Past to Present Min Seung Kim, Don Gueu Park, Jung Han Yoon Journal of Movement Disorders.2022; 15(3): 284. CrossRef
Three hertz orthostatic tremor as "red flag sign" candidate for multiple system atrophy Yuzhou Wang, Churong Liu, Wenhua Zheng, Mengyun Li, Xiaodi Li Neurological Sciences.2025; 46(3): 1217. CrossRef
Orthostatic Tremor José Fidel Baizabal-Carvallo, Joseph Jankovic Seminars in Neurology.2025;[Epub] CrossRef
Tremor Syndromes: An Updated Review Abhishek Lenka, Joseph Jankovic Frontiers in Neurology.2021;[Epub] CrossRef
Objective Impulse control disorders (ICDs) in Parkinson’s disease (PD) are mostly related to dopamine replacement therapy (DRT); however, drug-naïve PD patients have also frequently experienced impulsivity. This phenomenon makes clinicians hesitate treating patients with DRT. In this study, we assessed the effect of impulsivity on quality of life (QOL) in drug-naïve PD patients.
Methods Two hundred three newly diagnosed, nonmedicated PD patients were enrolled, and they received structured clinical interviews, physical examinations and validated questionnaires to evaluate motor and nonmotor symptoms and QOL. Impulsivity was evaluated using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS).
Results Thirty-eight patients (18.7%) had impulsivity with QUIP-RS scores ≥ 1 and 4 patients (2.0%) were diagnosed with combined ICDs. Motor and nonmotor symptoms were significantly correlated with the Parkinson’s Disease Questionnaire-39 summary index. Female sex and QUIP-RS scores were also correlated with QOL in drug-naïve PD patients.
Conclusion The results of the present study showed that impulsivity negatively influences QOL in early drug-naïve PD patients. In addition, more severe motor and nonmotor symptoms were also associated with lower QOL. Such findings complicate treatment but provide valuable information for managing early PD.
Citations
Citations to this article as recorded by
Is GBA1 mutation status a game-changer for impulse control behaviour in Parkinson's disease? Nikola Kresojević, Vladana Marković, Cveta Geratović, Milica Ječmenica Lukić, Aleksandra Tomić, Valerija Dobričić, Iva Stanković, Tanja Stojković, Nataša Dragašević, Maksim Šarčević, Milena Janković, Ana Marjanović, Ivana Novaković, Vladimir Kostić, Marin Neurological Sciences.2025; 46(11): 5829. CrossRef
Frequency of Impulsive-Compulsive Behavior and Associated Psychological Factors in Parkinson’s Disease: Lack of Control or Too Much of It? Alexandros Kapsomenakis, Dimitrios Kasselimis, Emily Vaniotis, Anastasia Bougea, Christos Koros, Athina Maria Simitsi, Leonidas Stefanis, Constantin Potagas Medicina.2023; 59(11): 1942. CrossRef
Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy Rong Ye, Frank H. Hezemans, Claire O'Callaghan, Kamen A. Tsvetanov, Catarina Rua, P. Simon Jones, Negin Holland, Maura Malpetti, Alexander G. Murley, Roger A. Barker, Caroline H. Williams-Gray, Trevor W. Robbins, Luca Passamonti, James B. Rowe The Journal of Neuroscience.2023; 43(42): 7028. CrossRef
Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation Weibing Liu, Tatsuya Yamamoto, Yoshitaka Yamanaka, Masato Asahina, Tomoyuki Uchiyama, Shigeki Hirano, Keisuke Shimizu, Yoshinori Higuchi, Satoshi Kuwabara Frontiers in Neurology.2021;[Epub] CrossRef
Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease Alison Hall, Samuel R. Weaver, Lindsey J. Compton, Winston D. Byblow, Ned Jenkinson, Hayley J. MacDonald Clinical Parkinsonism & Related Disorders.2021; 5: 100113. CrossRef
A Review of the Concept of Impulsivity Mohammed Munther Al-Hammouri, Jehad A. Rababah, Celeste Shawler Advances in Nursing Science.2021; 44(4): 357. CrossRef
Assessment of therapeutic strategies for management of impulse control disorder in Parkinson’s disease Mayela Rodríguez-Violante, Yazmín Ríos-Solís, Oscar Esquivel-Zapata, Fanny Herrera, Susana López-Alamillo, Cynthia Sarabia-Tapia, Amin Cervantes-Arriaga Arquivos de Neuro-Psiquiatria.2021; 79(11): 989. CrossRef
High throughput 3D gel-based neural organotypic model for cellular assays using fluorescence biosensors Srikanya Kundu, Molly E. Boutin, Caroline E. Strong, Ty Voss, Marc Ferrer Communications Biology.2022;[Epub] CrossRef